32.03
5.36%
1.63
After Hours:
32.03
Atricure Inc stock is traded at $32.03, with a volume of 432.66K.
It is up +5.36% in the last 24 hours and down -11.32% over the past month.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.
See More
Previous Close:
$30.40
Open:
$30.58
24h Volume:
432.66K
Relative Volume:
0.91
Market Cap:
$1.56B
Revenue:
$447.57M
Net Income/Loss:
$-38.92M
P/E Ratio:
-38.59
EPS:
-0.83
Net Cash Flow:
$-1.15M
1W Performance:
+4.50%
1M Performance:
-11.32%
6M Performance:
+42.67%
1Y Performance:
-4.96%
Atricure Inc Stock (ATRC) Company Profile
Name
Atricure Inc
Sector
Industry
Phone
513-755-4100
Address
7555 INNOVATION WAY, MASON, OH
Compare ATRC with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
ATRC
Atricure Inc
|
32.03 | 1.56B | 447.57M | -38.92M | -1.15M | -0.83 |
ISRG
Intuitive Surgical Inc
|
535.29 | 190.66B | 7.87B | 2.24B | 586.00M | 6.22 |
BDX
Becton Dickinson Co
|
228.46 | 66.26B | 20.18B | 1.71B | 3.07B | 5.94 |
ALC
Alcon Inc
|
84.06 | 41.58B | 9.76B | 1.16B | 665.00M | 2.34 |
RMD
Resmed Inc
|
231.67 | 34.01B | 4.81B | 1.11B | 1.35B | 7.55 |
WST
West Pharmaceutical Services Inc
|
335.56 | 24.30B | 2.88B | 499.60M | 321.60M | 6.74 |
Atricure Inc Stock (ATRC) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Dec-17-24 | Resumed | JP Morgan | Overweight |
Apr-23-24 | Upgrade | Oppenheimer | Perform → Outperform |
Oct-23-23 | Initiated | JMP Securities | Mkt Outperform |
Sep-29-23 | Initiated | UBS | Buy |
Aug-05-21 | Downgrade | Oppenheimer | Outperform → Perform |
Dec-18-20 | Reiterated | Needham | Buy |
Nov-06-20 | Reiterated | Needham | Buy |
Apr-07-20 | Initiated | Oppenheimer | Outperform |
Feb-06-20 | Initiated | BTIG Research | Buy |
Jan-24-20 | Reiterated | Needham | Buy |
Aug-13-19 | Downgrade | Northland Capital | Outperform → Market Perform |
Apr-12-19 | Initiated | JP Morgan | Overweight |
Oct-04-18 | Reiterated | Needham | Buy |
Aug-02-18 | Reiterated | Needham | Buy |
Aug-02-18 | Reiterated | Stifel | Buy |
Jun-18-18 | Reiterated | Needham | Buy |
Apr-27-18 | Reiterated | Needham | Buy |
Jan-16-18 | Reiterated | Needham | Buy |
Nov-02-17 | Reiterated | Needham | Buy |
Jul-28-17 | Reiterated | Needham | Buy |
May-30-17 | Resumed | Piper Jaffray | Overweight |
Jun-30-16 | Resumed | JMP Securities | Mkt Outperform |
Oct-28-15 | Reiterated | Needham | Buy |
Oct-06-15 | Reiterated | Canaccord Genuity | Buy |
Oct-06-15 | Reiterated | Needham | Buy |
View All
Atricure Inc Stock (ATRC) Latest News
How the (ATRC) price action is used to our Advantage - Stock Traders Daily
AtriCure, Inc. (NASDAQ:ATRC) Short Interest Down 5.3% in December - MarketBeat
Geode Capital Management LLC Boosts Stake in AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat
Left Atrial Appendage Closure Devices Market Poised for Tremendous Growth from 2024 to 2032 - openPR
Is AtriCure (NASDAQ:ATRC) Using Debt In A Risky Way? - Simply Wall St
(ATRC) Investment Analysis and Advice - Stock Traders Daily
AtriCure to Participate in the 43rd Annual J.P. Morgan Healthcare Conference - Business Wire
Barclays PLC Has $3.63 Million Stake in AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat
State Street Corp Purchases 63,002 Shares of AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat
AtriCure (NASDAQ:ATRC) Given Overweight Rating at JPMorgan Chase & Co. - MarketBeat
21,884 Shares in AtriCure, Inc. (NASDAQ:ATRC) Bought by Y Intercept Hong Kong Ltd - MarketBeat
Orion Portfolio Solutions LLC Sells 40,829 Shares of AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat
BNP Paribas Financial Markets Lowers Stock Holdings in AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat
AtriCure, Inc. (NASDAQ:ATRC) Receives $42.00 Average Target Price from Analysts - MarketBeat
(ATRC) Investment Analysis - Stock Traders Daily
Fmr LLC Has $27.30 Million Stock Position in AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat
Cracking The Code: Understanding Analyst Reviews For AtriCure - Inkl
Two Sigma Advisers LP Has $18.62 Million Stock Holdings in AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat
AtriCure Inc (ATRC) Trading Down 3.18% on Dec 5 - GuruFocus.com
AtriCure Inc (ATRC) Shares Gap Down to $36.21 on Dec 3 - GuruFocus.com
AtriCure (NASDAQ:ATRC) investors are sitting on a loss of 45% if they invested three years ago - Simply Wall St
Atom Investors LP Purchases Shares of 62,095 AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat
PDT Partners LLC Invests $665,000 in AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat
Bridgewater Associates LP Sells 20,632 Shares of AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat
Intech Investment Management LLC Buys New Position in AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat
Healthcare of Ontario Pension Plan Trust Fund Invests $1.99 Million in AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat
How To Trade (ATRC) - Stock Traders Daily
Wasatch Advisors LP Trims Stock Position in AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat
Short Interest in AtriCure, Inc. (NASDAQ:ATRC) Declines By 25.8% - MarketBeat
BNP PARIBAS ASSET MANAGEMENT Holding S.A. Has $14.04 Million Stake in AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat
Connor Clark & Lunn Investment Management Ltd. Buys 52,533 Shares of AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat
B. Metzler seel. Sohn & Co. Holding AG Purchases Shares of 31,366 AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat
Trend Tracker for (ATRC) - Stock Traders Daily
AtriCure Inc. loses $24 million in value following the election (See how it affected others) - The Business Journals
AtriCure to Present at Piper Sandler Healthcare Conference in December | ATRC Stock News - StockTitan
AtriCure to Participate in the Piper Sandler 36th Annual Healthcare Conference - Business Wire
AtriCure, Inc. (NASDAQ:ATRC) Receives $43.11 Average Price Target from Analysts - MarketBeat
What to Expect from AtriCure - AOL
Assetmark Inc. Has $39,000 Position in AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat
Hood River Capital Management LLC Bolsters Stake in AtriCure Inc. - GuruFocus.com
Short Interest in AtriCure, Inc. (NASDAQ:ATRC) Declines By 31.6% - MarketBeat
AtriCure Inc (ATRC) Stock Price Down 3.06% on Nov 12 - GuruFocus.com
(ATRC) Pivots Trading Plans and Risk Controls - Stock Traders Daily
AtriCure to Participate in the Stifel 2024 Healthcare Conference - StockTitan
A Piece Of The Puzzle Missing From AtriCure, Inc.'s (NASDAQ:ATRC) 28% Share Price Climb - Simply Wall St
AtriCure (ATRC) Stock Surges Over 5% Amid Market Volatility - GuruFocus.com
AtriCure Inc (ATRC) Shares Up 3.58% on Nov 5 - GuruFocus.com
Emerald Advisers LLC Acquires 38,421 Shares of AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat
Atricure Inc Stock (ATRC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):